Unknown

Dataset Information

0

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.


ABSTRACT: To evaluate the clinical relevance of myelin oligodendrocyte glycoprotein antibody (MOG-Ab) in a cohort of adults with inflammatory demyelinating disease (IDD) of the CNS.Live cell-based assays for MOG-Ab (IgG1 subset) and antibody to aquaporin-4 (AQP4-Ab) were performed in a cohort of 270 adult patients with IDD and 72 controls. Patients were first grouped by positive antibody result as MOG-Ab or AQP4-Ab, and the remainder were grouped by published diagnostic criteria.Seventeen patients with IDD (6.3%) had MOG-Abs and 49 patients (18.1%) had AQP4-Abs; none had both antibodies. The MOG-Ab patients predominantly manifested with isolated symptoms of optic neuritis (83%). One-third of these patients experienced relapses, which involved only the optic nerve, and all relapsed within 1 year of disease onset. At onset, MRI in the MOG-Ab group uniquely demonstrated perineural enhancement, extending to the soft tissues around the optic nerves (33%). Although about 30% of MOG-Ab patients had brain MRI lesions, they had fewer periventricular lesions than the 26 patients with relapsing-remitting multiple sclerosis (MS); none of these lesions were ovoid or perpendicular to the ventricle. Moreover, MOG-Ab patients did not meet the diagnostic criteria for definite neuromyelitis optica (NMO) and had less spinal cord involvement than the AQP4-Ab group. Four patients (23.5%) had poor visual outcomes (<0.2) or paraplegia.MOG-Abs may be a disease-specific biomarker in adult patients with IDD who have a disease distinct from NMO or MS. The radiologic as well as clinical manifestations of MOG-Ab patients can be useful in their differential diagnosis.

SUBMITTER: Kim SM 

PROVIDER: S-EPMC4608758 | BioStudies | 2015-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4824843 | BioStudies
1000-01-01 | S-EPMC4370386 | BioStudies
1000-01-01 | S-EPMC4215392 | BioStudies
2011-01-01 | S-EPMC3278385 | BioStudies
1000-01-01 | S-EPMC3048150 | BioStudies
2020-01-01 | S-EPMC7326092 | BioStudies
1000-01-01 | S-EPMC5182057 | BioStudies
1000-01-01 | S-EPMC4841645 | BioStudies
1000-01-01 | S-EPMC6208174 | BioStudies
1000-01-01 | S-EPMC6206299 | BioStudies